An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes

NCT02962492 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Evaluate Ketogenic Stress

Interventions

DRUG: Exenatide/Exenatide extended release
DRUG: Dapagliflozin
DRUG: Placebo

Sponsor

University at Buffalo

Collaborators

[object Object]